Melatonin Niosome Gel vs. Chloral Hydrate for Sedation in Children Undergoing Auditory Brainstem Response: a Randomized Controlled Trial Melatonin niosome gel vs. chloral hydrate for pediatric ABR testing
Article Sidebar
Main Article Content
Abstract
OBJECTIVE: To compare the success rate of auditory brainstem response (ABR) testing after the application of melatonin niosome gel (MNG) versus chloral hydrate in children aged 1 to 6 years.
METHODS: A double-blinded, randomized, controlled trial was conducted. Participants in the MNG group were given 250 mg of MNG (5 mg melatonin) for sedation prior to the ABR test, and those in the chloral hydrate group were given chloral hydrate syrup, 50 mg/kg with an additional dose of 25 mg/kg if they didn’t fall asleep within 30 min. The study was conducted in the morning; all the participants were prepared in accordance with protocols similar to the regular ABR protocols.
RESULTS: Twenty-four children were enrolled, and 16 participants passed the screening and were randomized into 2 groups. The success rate of ABR in the MNG group was 25.0% compared to 100.0% in the chloral hydrate group (p-value = 0.01). Twenty-five percent of the subjects in the chloral hydrate group required a second dose of choral hydrate. The average sleep onset latency of the chloral hydrate group was 25.1 min, which was approximately the same as the MNG group (25.4 min). The average sleep duration of the chloral hydrate group was 89.3 min, which was significantly longer than the MNG group (45.6 min), with a mean difference of 43.6 min (p-value = 0.01). There were minor adverse events in both groups, including vomiting (12.5 – 25.0%) and irritability (25.0%), without any serious adverse events reported.
CONCLUSION: The sedative effect of trans-mucosal MNG was unfavorable comparing with the chloral hydrate. The sublingual delivery was intolerance for uncooperative children and sedation for neurodevelopment disordered children were challenging. However, the sleep onset latency by behavioral observation induced by MNG tended to be comparable to chloral hydrate. Further adjustment of trans-mucosal administration and dosage could provide adequate pediatric sedation.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Valenzuela DG, Kumar DS, Atkins CL, Beers A, Kozak FK, Chadha NK. Chloral hydrate sedation for auditory brainstem response (ABR) testing in children: safety and effectiveness. Int J Pediatr Otorhinolaryngol 2016;83:175-8.
Sury M, Bullock I, Rabar S, Demott K. Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance. BMJ 2010;341:c6819.
Reynolds J, Rogers A, Medellin E, Guzman JA, Watcha MF. A prospective, randomized, double-blind trial of intranasal dexmedetomidine and oral chloral hydrate for sedated auditory brainstem response (ABR) testing. Paediatr Anaesth 2016;26(3):286-93.
Kao SC, Adamson SD, Tatman LH, Berbaum KS. A survey of post-discharge side effects of conscious sedation using chloral hydrate in pediatric CT and MR imaging. Pediatr Radiol 1999;29(4):287-90.
Pattaravit N, Karnjanawanichkul O, Uakritdathikarn Th, Thinchana S. Incidence and predictors of emergence agitation in pediatric patients who received chloral hydrate for premedication. Songkla Med J 2010;28(5):257-66.
Jan MM, Aquino MF. The use of choral hydrate in pediatric electroencephalography. Neurosci J (Riyadh) 2001;6(2):99-102.
Behrman DB, Bishop JL, Godsell J, Shirley B, Storey S, Carroll WW, et al. Efficacy of melatonin for auditory brainstem response testing in children: a systematic review. Int J Pediatr Otorhinolaryngol 2020;131:109861.
Casteil L, Viquesnel A, Favier V, Guignard N, Blanchet C, Mondain M. Study of the efficacy of melatonin for auditory brainstem response (ABR) testing in children. Eur Ann Otorhinolaryngol Head Neck Dis 2017;134(6):373-5.
Fourtillan JB, Brisson AM, Gobin P, Ingrand I, Decourt JP, Girault J. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. Biopharm Drug Dispos 2000;21(1):15-22.
DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS Jr. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000;40(7):781-4.
Priprem A, Nukulkit C, Johns NP, Laohasiriwong S, Yimtae K, Soontornpas C. Transmucosal delivery of melatonin-encapsulated niosomes in a mucoadhesive gel. Ther Deliv 2018;9(5):343-57.
Uthaiwat P, Priprem A, Puthongking P, Daduang J, Nukulkit C, Chio-Srichan S, et al. Characteristic evaluation of gel formulation containing niosomes of melatonin or its derivative and mucoadhesive properties using ATR-FTIR spectroscopy. Polymers (Basel) 2021;13(7):1142.
Andersen LP, Werner MU, Rosenkilde MM, Harpsøe NG, Fuglsang H, Rosenberg J, et al. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol 2016;17:8.
Schmidt CM, Knief A, Deuster D, Matulat P, am Zehnhoff-Dinnesen AG. Melatonin is a useful alternative to sedation in children undergoing brainstem audiometry with an age dependent success rate--a field report of 250 investigations. Neuropediatrics 2007;38(1):2-4.
Guerlain J, Paul A, Rouillon I, Parodi M, Garabedian EN, Loundon N. Efficiency of melatonin as compared to pentobarbital for audiometry brainstem response in children with associated disorders. Am J Audiol 2016;25(3):206-10.
British Medical Association. BNF for children 2016-2017. London: Pharmaceutical; 2017.
Malach M, Berman N. Furosemide and chloral hydrate. Adverse drug interaction. JAMA 1975;232(6):638-9.
Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 2000;49(5):423-7.
Ogilvie BW, Torres R, Dressman MA, Kramer WG, Baroldi P. Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist. J Clin Pharmacol 2015;55(9):1004-11.
Shaki F, Ashari S, Ahangar N. Melatonin can attenuate ciprofloxacin induced nephrotoxicity: involvement of nitric oxide and TNF-α. Biomed Pharmacother 2016;84:1172-8.
Cote CJ, Wilson S, American academy of pediatrics, American academy of pediatric dentistry. Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016. Pediatrics 2016;138(1): e2-31.
Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 2009;4(11):1832-43.
Cortesi F, Giannotti F, Ivanenko A, Johnson K. Sleep in children with autistic spectrum disorder. Sleep Med 2010;11(7):659-64.
Giménez S, Altuna M, Blessing E, Osorio RM, Fortea J. Sleep disorders in adults with down syndrome. J Clin Med 2021;10(14):3012.
Hvolby A. Associations of sleep disturbance with ADHD: implications for treatment. Atten Def Hyp Disord 2015;7(1):1-18.
Tolaymat A, Liu Z. Sleep disorders in childhood neurological diseases. Children (Basel) 2017; 4(10):84.
Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol 2015;79(3):395-404.
Bénès L, Claustrat B, Horrière F, Geoffriau M, Konsil J, Parrott KA, et al. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J Pharm Sci 1997;86(10):1115-9.
Tobias J, Leder M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth 2011;5(4):395-410.
U.S department of health and human services, national institutes of health, national cancer institute. Common terminology criteria for adverse events (CTCAE) [internet]. 2017 [cited 2020 Jun 15]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50
Harriet Lane Service (Johns Hopkins Hospital). The Harriet Lane handbook: a manual for pediatric house officers. 21st ed. Philadelphia: Elsevier; 2018.
Chaouki A, El Krimi Z, Mkhatri A, Youssef O, Rouadi S, Abada R, et al. Efficiency of melatonin as a sedative for auditory brainstem response in children. Audiol Res 2020;10(2):50-4.
Hajjij A, Tahiri I, Anajar S, Essaadi M, Snoussi K. Melatonin is useful alternative for sedation in children undergoing auditory brainstem responses testing. Eur J Pediatr 2020;179(9):1431-4.